Trial: 202004247

A PHASE 1/2, OPEN-LABEL, MULTICENTER STUDY TO INVESTIGATE THE SAFETY AND PRELIMINARY EFFICACY OF NKTR-214 IN COMBINATION WITH PEMBROLIZUMAB IN PATIENTS WITH LOCALLY ADVANCED OR METASTATIC SOLID TUMORS

Phase

I/II (Cancer Control)

Principal Investigator

Govindan, Ramaswamy

Disease Site

Larynx; Lip, Oral Cavity and Pharynx; Liver; Lung; Lung Cancer – Non-small Cell; Melanoma, Skin; Urinary Bladder

Learn more about this study at: clinicaltrials.gov